Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.807 | 0.160 | 7 | 17328796 | intron variant | T/C | snv | 0.81 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.807 | 0.160 | 7 | 17328796 | intron variant | T/C | snv | 0.81 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.807 | 0.160 | 7 | 17328796 | intron variant | T/C | snv | 0.81 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.807 | 0.160 | 7 | 17328796 | intron variant | T/C | snv | 0.81 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.807 | 0.160 | 7 | 17328796 | intron variant | T/C | snv | 0.81 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.807 | 0.160 | 7 | 17328796 | intron variant | T/C | snv | 0.81 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.040 | 7 | 17298806 | 5 prime UTR variant | A/G | snv | 0.79 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.040 | 7 | 17298806 | 5 prime UTR variant | A/G | snv | 0.79 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.040 | 7 | 17298806 | 5 prime UTR variant | A/G | snv | 0.79 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.882 | 0.080 | 7 | 17331739 | intron variant | A/G | snv | 0.76 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2009 | 2018 | |||||||
|
0.882 | 0.080 | 7 | 17331739 | intron variant | A/G | snv | 0.76 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2009 | 2018 | |||||||
|
0.882 | 0.080 | 7 | 17331739 | intron variant | A/G | snv | 0.76 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2009 | 2018 | |||||||
|
0.882 | 0.160 | 7 | 17244953 | intron variant | T/C | snv | 0.54 |
|
0.030 | 1.000 | 3 | 2012 | 2017 | ||||||||
|
0.882 | 0.160 | 7 | 17244953 | intron variant | T/C | snv | 0.54 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.882 | 0.160 | 7 | 17244953 | intron variant | T/C | snv | 0.54 |
|
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.160 | 7 | 17244953 | intron variant | T/C | snv | 0.54 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.882 | 0.160 | 7 | 17244953 | intron variant | T/C | snv | 0.54 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.160 | 7 | 17244953 | intron variant | T/C | snv | 0.54 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.882 | 0.160 | 7 | 17244953 | intron variant | T/C | snv | 0.54 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | < 0.001 | 1 | 2017 | 2017 | |||||||
|
0.882 | 0.160 | 7 | 17244953 | intron variant | T/C | snv | 0.54 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | < 0.001 | 1 | 2017 | 2017 | |||||||
|
0.882 | 0.160 | 7 | 17244953 | intron variant | T/C | snv | 0.54 |
|
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
7 | 17247645 | 5 prime UTR variant | A/T | snv | 0.54 |
|
0.020 | 1.000 | 2 | 2012 | 2016 | ||||||||||
|
0.827 | 0.120 | 7 | 17157947 | intron variant | C/T | snv | 0.49 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.827 | 0.120 | 7 | 17157947 | intron variant | C/T | snv | 0.49 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.827 | 0.120 | 7 | 17157947 | intron variant | C/T | snv | 0.49 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 |